Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of colistimethate sodium for carbapenem-resistant Gram-negative bacilli infection
ChiCTR2100054085Phase 4Recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistimethate sodium in sepsis, sponsored by Henan Provincial People's Hospital. Primary endpoints: Clinical improvement rate, All-cause mortality rate and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
colistimethate sodium
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2100054085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054085.